glp 1 and autoimmune disease Glucagon-like peptide-1 receptor agonists in arthritis: current insights future directions GLP-1 Agonists in Autoimmune Disease

GLP-1: Glucagon-Like Peptide-1 An incretin hormone that stimulates insulin secretion, reduces glucagon release, slows gastric emptying, and Suppresses appetite, aiding weight loss

Looking forward to connecting with more people working in bioprocess and CDMO spaces

All GLP-1 receptor agonists carry a boxed warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and are contraindicated in patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2

In the ever-evolving GLP-1 market landscape, OPTAVIA provides support to meet the needs of customers in all stages of their health journey, including those utilizing GLP-1 medications.

If pain persists across multiple injections, contact your PlexusDx provider to confirm your injection technique and needle size